Selected Publications

Myers RM, Li Y, Liu H, Mumanachit S, Wang L, Barz Leahy A, Cain LE, DiNofia AM, Diorio C, Freedman JL, Hunger SP, Maude SL, McClory SE, Rheingold SR, Tasian SK, Wray L, Olson TS, Grupp SA, Bunin NJ, Seif AE, Elgarten CW: Hematopoietic cell transplantation after CD19-directed CAR T-cell therapy for remission consolidation or relapse treatment in pediatric acute lymphoblastic leukemia. Haematologica Nov 2025.

Cairo M, Talano A, Flower A, Schaefer E, Wang Y, Li Y, Ayello J, Harrison L, Chu Y, Liao Y, Cooke K, Verneris M, Chu J, Dvorak C, Shenoy S, Goebel W, Kapoor N, Abu-Arja R, Elgarten CW, Jacob A, Vella L, Bunin N, Lee D : FINAL RESULTS OF THE SAFETY AND EFFICACY OF RELATED DONOR-DERIVED CMV AND ADENOVIRUS(ADV) CYTOTOXIC T-LYMPHOCYTES IN CHILDREN AND ADOLESCENTS WITH MEDICALLY REFRACTORY INFECTION. International Pediatric Oncology Conference, Amsterdam, Netherlands October 2025 Notes: Poster.

Vasileiadi E, Elgarten CW, Getz KD, Aplenc R, Fisher BT: Fluoroquinolone Susceptibility and Comparative Outcomes of Gram-negative Bloodstream Infection in Pediatric Patients With Hematologic Malignancy. J Pediatric Infect Dis Soc. 14(10), Oct 2025.

Zheng DJ, Hettinger G, Bender JD, Boulter AC, Cao L, Elgarten CW, Fisher BT, Gathers C, Huang YV, Ko J, Leger KJ, Li Y, Myers R, Narayan HK, Ortiz J, Seif AE, Vasileiadi E, Aplenc R, Getz KD: National Trends in Dexrazoxane and Cardiovascular Health Care Utilization for Children With Acute Myeloid Leukemia. JAMA Oncology Oct 2025.

S. Sheikh, V. Derebail, N. Grover, G. Gulati, M. Abedi, M. Sise, M. Frigault, C. Palma, P. Reagan, C. Edens, S. Kosuri, C. Elgarten, J. Burnham, C. Edens, K. Satyajit, J. Hogan, Y. White, C. DiCasoli, R. Estremera, J. Volkov, D. Nunez, F. Hadi-Nezhad, T. Furmanak, J. Stadanlick, L. Ishikawa, Z. Vorndran, A. Ellis, J. Williams, S. Flanagan, Q. Lam, S. Basu, R. Tummala, D. Chang: RESET SLE: Clinical Trial Evaluating Rese-cel (Resecabtagene Autoleucel), a Fully Human, Autologous 4-1BB CD19-CAR T Cell Therapy in Non-Renal SLE and Lupus Nephritis. American College of Rheumatology Annual Meeting, Chicago, IL October 2025 Notes: Poster.

AML Care at Home: An Evidence-Based Toolkit to Personalize the Care Setting for Recovery From Pediatric AML Chemotherapy: Seif AE, McDonough SL, Becker-Haimes EM, Oranges KE, Clerico D, Hartman J, Rodock K, Schwartz LA, Elgarten CW, Myers RM, Puszczynski RO, Rheingold SR, Stern JW, Jubelirer TF, Armideo EA, Evageliou NF, Randall RJ, Bernt KM, Reilly AF, Tasian SK, Diamant RK, Fisher BT, Getz KD, Aplenc R. JCO Oncol Pract Sep 2025.

Wobma H, Ardoin SP, Bonifant CL, Cooper JC, Kim H, Sadun RE, Lewandowski L, Keller M, Colbert RA, Edens C, DeQuattro K, Driest K, Shalen J, Stojkic I, Knight A, Annesley C, Torok KS, Elgarten CW, Onishi T, Jackson SW, Prockop S, Shah NN, Ardalan K, Lamb M; Integrated Multidisciplinary Paediatric Autoimmunity and Cell Therapy (IMPACT) working group*.: CAR T cell therapy for children with rheumatic disease: the time is now. Nat Rev Rheumatol 21(8): 494-506, Aug 2025.

Zheng DJ, Hettinger G, Aftandilian C, Bona K, Caywood EH, Collier AB, Elgarten CW, Gathers C, Ghosh T, Gramatges MM, Henry M, Huang YV, Li Y, Lotterman C, Maloney K, Mian A, Miller TP, Modi A, Mody R, Morgan E, Myers R, Newman H, Ortiz J, Seif AE, Smith C, Stokke J, Wang X, Winick N, Wilkes JJ, Wong V, Aplenc R, Getz KD: Real-world generalizability of clinical trial cytomolecular risk in pediatric acute myeloid leukemia: a report from the REAL-AML cohort. J Natl Cancer Inst Aug 2025.

Gibson NM, Elgarten CW, Oved JH, Wray L, Freedman J, Khandros E, Worster E, Nicholas P, Kadauke S, Wang Y, Grupp S, Kwiatkowski JL, Olson TS.: Outcomes of Unrelated Donor Stem Cell Transplantation with Partial T Cell Depletion for Pediatric Patients with Hemoglobinopathies. Transplant Cell Ther S2666-6367(25): 01272-2, Jul 2025.

Gibson NM, Khandros E, Elgarten CW, Worster E, Monos DS, Thompson AA, Kwiatkowski JL, Olson T.: Impact of HLA Alloimmunization in Gene-Modified Autologous Stem Cell Transplant For Transfusion-Dependent Thalassemia. Blood 145(22): 2666-2670, Mar 2025 Notes: DOI: 10.1182/blood.2024027034